Cutaneous Melanomas Associated with Nevi

Archives of Dermatology

Volumn 139, Issue 12, 2003, Pages 1620-1624

  Bevona, Caroline ^a,d   Goggins, William ^b   Quinn, Timothy ^c   Fullerton, Julie ^a   Tsao, Hensin ^a   Corona, Rosamaria ^e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c Pathology Services Inc Cambridge   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; CHILD; DISEASE ASSOCIATION; DYSPLASTIC NEVUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THICKNESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COMPUTER GRAPHICS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, MULTIPLE PRIMARY; NEVUS; ODDS RATIO; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 0347504782     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.12.1620     Document Type: Review

References (28)

1. Elder DE, Clark WH Jr, Elenitsas R, Guerry D IV, Halpern AC. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol. 1993; 10:18-35.
2. Elder DE, Greene MH, Bondi EE, Clark WHJ. Acquired melanocytic nevi and melanoma: the dysplastic nevus syndrome. In: Ackerman AB, ed. Pathology of Malignant Melanoma. New York, NY: Masson; 1981:185-216.
3. Stolz W, Schmoeckel C, Landthaler M, Braun-Falco O. Association of early malignant melanoma with nevocytic nevi. Cancer. 1989;63:550-555.
4. Black WC. Residual dysplastic and other nevi in superficial spreading melanoma: clinical correlations and association with sun damage. Cancer. 1988;62: 163-173.
5. Clark WH Jr, Elder DE, Guerry D IV, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984;15:1147-1165.
6. Cook MG, Robertson I. Melanocytic dysplasia and melanoma. Histopathology. 1985;9:647-658.
7. Gruber SB, Barnhill RL, Stenn KS, Roush GC. Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. J Am Acad Dermatol. 1989;21:773-780.
8. Harley S, Walsh N. A new look at nevus-associated melanomas. Am J Dermatopathol. 1996;18:137-141.
9. Hastrup N, Osterlind A, Drzewiecki KT, Hou-Jensen K. The presence of dysplastic nevus remnants in malignant melanomas: a population-based study of 551 malignant melanomas. Am J Dermatopathol. 1991;13:378-385.
10. Marks R, Dorevitch AP, Mason G. Do all melanomas come from "moles"? a study of the histological association between melanocytic naevi and melanoma. Australas J Dermatol. 1990;31:77-80.
11. Massi D, Carli P, Franchi A, Santucci M. Naevus-associated melanomas: cause or chance? Melanoma Res. 1999;9:85-91.
12. Rhodes AR, Harrist TJ, Day CL, Mihm MC Jr, Fitzpatrick TB, Sober AJ. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol. 1983;9:563-574.
13. Sagebiel RW. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness. J Invest Dermatol. 1993;100:322S-325S.
14. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol. 1995;33: 1000-1007.
15. McGovern VJ, Shaw HM, Milton GW. Histogenesis of malignant melanoma with an adjacent component of the superficial spreading type. Pathology. 1985;17: 251-254.
16. Rhodes AR, Sober AJ, Day CL, et al. The malignant potential of small congenital nevocellular nevi: an estimate of association based on a histologic study of 234 primary cutaneous melanomas. J Am Acad Dermatol. 1982;6:230-241.
17. Sondergaard K. Histological type and biological behavior of primary cutaneous malignant melanoma, I: an analysis of 1916 cases. Virchows Arch A Pathol Anat Histopathol. 1983;401:315-331.
18. Kopf AW, Welkovich B, Frankel RE, et al. Thickness of malignant melanoma: global analysis of related factors. J Dermatol Surg Oncol. 1987;13:345-390, 401-420.
19. Tsao H, Bevona C, Goggins W, Quinn T. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. Arch Dermatol. 2003;139:282-288.
20. Consensus conference: precursors to malignant melanoma. JAMA. 1984;251: 1864-1866.
21. Greene MH. Genetics of cutaneous melanoma and nevi. Mayo Clin Proc. 1997; 72:467-474.
22. Kraemer KH, Greene MH, Tarone R, Elder DE, Clark WH Jr, Guerry D IV. Dysplastic naevi and cutaneous melanoma risk. Lancet. 1983;2:1076-1077.
23. Mooi WJ. The dysplastic naevus. J Clin Pathol. 1997;50:711-715.
24. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA. 1997;277:1439-1444.
25. Elder DE, Murphy GF. Melanocytic tumors of the skin. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 1991. 3rd series, fascicle 2.
26. Friedman RJ, Rigel DS, Kopf AW, et al. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi. Arch Dermatol. 1983;119: 455-462.
27. Nicholls EM. Development and elimination of pigmented moles, and the anatomical distribution of primary malignant melanoma. Cancer. 1973;32:191-195.
28. MacKie RM, English J, Aitchison TC, Fitzsimons CP, Wilson P. The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol. 1985;113:167-174 tures of DN and melanoma.